Pittsburgh-based LyGenesis receives FDA clearance for new drug application

The company can now move forward with a study and clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.